MD Anderson and Sanofi Announce Strategic Collaboration to Accelerate Oncology Research and Development
July 15, 2020
July 15, 2020
HOUSTON, Texas, July 15 -- The University of Texas's MD Anderson Cancer Center issued the following news release:
The University of Texas MD Anderson Cancer Center and Sanofi announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer. The alliance will combine MD Anderson's clinical trials infrastructure and Sanofi's pipeline of investigational treatments to lead biomark . . .
The University of Texas MD Anderson Cancer Center and Sanofi announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer. The alliance will combine MD Anderson's clinical trials infrastructure and Sanofi's pipeline of investigational treatments to lead biomark . . .